HOCPF(HOCPF)
HOCPF
No analyst ratings available
No analyst price targets available for HOCPF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $1.03T | $1.10T | $1.20T | $1.34T | $1.47T |
| Low | $997.70B | $1.06T | $1.15T | $1.29T | $1.41T |
| High | $1.05T | $1.14T | $1.23T | $1.38T | $1.51T |
| EBITDA Avg | $362.66B | $389.28B | $421.63B | $473.31B | $516.89B |
| Low | $351.54B | $371.76B | $405.57B | $455.28B | $497.20B |
| High | $371.54B | $401.22B | $433.30B | $486.41B | $531.20B |
| EBIT Avg | $311.52B | $334.40B | $362.18B | $406.57B | $444.01B |
| Low | $301.98B | $319.35B | $348.38B | $391.08B | $427.10B |
| High | $319.15B | $344.65B | $372.21B | $417.83B | $456.30B |
| Net Income Avg | $271.97B | $307.70B | $346.46B | $409.02B | $464.13B |
| Low | $258.51B | $292.46B | $329.30B | $388.77B | $441.15B |
| High | $281.76B | $318.77B | $358.93B | $423.74B | $480.84B |
| EPS Avg | $799.33 | $904.32 | $1018.25 | $1202.12 | $1364.08 |
| Low | $759.75 | $859.54 | $967.82 | $1142.58 | $1296.53 |
| High | $828.10 | $936.87 | $1054.89 | $1245.38 | $1413.18 |
| Analysts (Rev / EPS) | 15 / 1 | 15 / 1 | 11 / 1 | 7 / 1 | 6 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $258.50B | $265.66B | $265.90B |
| Low | $253.42B | $260.44B | $260.67B |
| High | $262.25B | $269.51B | $269.76B |
| EBITDA Avg | $91.08B | $93.61B | $93.69B |
| Low | $89.29B | $91.76B | $91.85B |
| High | $92.41B | $94.96B | $95.05B |
| EBIT Avg | $78.24B | $80.41B | $80.48B |
| Low | $76.70B | $78.83B | $78.90B |
| High | $79.38B | $81.57B | $81.65B |
| Net Income Avg | $65.39B | $68.23B | $71.37B |
| Low | $63.72B | $66.49B | $69.55B |
| High | $66.62B | $69.52B | $72.72B |
| EPS Avg | $194.21 | $202.66 | $211.97 |
| Low | $189.24 | $197.48 | $206.56 |
| High | $197.87 | $206.48 | $215.97 |
| Analysts (Rev / EPS) | 7 / 1 | 4 / 1 | 4 / 1 |